Press release from University of Dundee (re bronchiestasis) May2022
ProAxsis releases new NEATstik® data at the Irish Thoracic Society Conference 2021
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis CEO attending DxPx conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis presents exciting new data at the ERS International Congress 2021
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
Aptamer Group and ProAxsis Limited enter partnership to improve global logistics and stability of diagnostic tests
ProAxsis Limited, the Belfast-based diagnostics company, today announces an expansion of its activities in Asia, via a partnership with Kyberlife, a Singapore-based company offering a novel e-commerce platform. The partnership will initially enable the company’s existing product portfolio, including laboratory-based assays for the active forms of Neutrophil Elastase and Proteinase 3, and a point-of-care test […]
ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
ProAxsis Limited, the Belfast-based diagnostics company, today announces an expansion of its activities in Asia, via a partnership with Kyberlife, a Singapore-based company offering a novel e-commerce platform. The partnership will initially enable the company’s existing product portfolio, including laboratory-based assays for the active forms of Neutrophil Elastase and Proteinase 3, and a point-of-care test […]
ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of Geneva and the University Hospital of Geneva, today announce that they have reached agreement on a global licensing agreement. Researchers at the University have developed a highly novel assay for a Cathepsin K-dependent periostin cleavage product, as a biomarker of bone fragility […]
ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis presenting new data at 2018 European Respiratory Society Conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis presenting further data at COPD 11 Conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
